Literature DB >> 9543380

Growth hormone and renal osteodystrophy: a case report.

D B Kaufman1.   

Abstract

A 14-year-old male with end-stage renal disease on hemodialysis was treated with recombinant growth hormone for growth retardation. He developed severe renal osteodystrophy, which responded only to the discontinuation of growth hormone.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9543380     DOI： 10.1007/s004670050429

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


  5 in total

1.  Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement.

Authors:  John D Mahan; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

Review 2.  Longitudinal growth in children following kidney transplantation: from conservative to pharmacological strategies.

Authors:  Tim Ulinski; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2006-05-10       Impact factor: 3.714

3.  Parathyroid hormone levels in pubertal uremic adolescents treated with growth hormone.

Authors:  Stefano Picca; Marco Cappa; Chiara Martinez; Seyoum Ido Moges; John Osborn; Francesco Perfumo; Gianluigi Ardissino; Roberto Bonaudo; Giovanni Montini; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

4.  Oral manifestations in a renal osteodystrophy patient - a case report with review of literature.

Authors:  Parthiban J; Aarthi Nisha V; Asokan Gs; Prakash Ca; Varadharaja Mm
Journal:  J Clin Diagn Res       Date:  2014-08-20

Review 5.  Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective.

Authors:  Richard N Fine
Journal:  Pediatr Nephrol       Date:  2009-12-24       Impact factor: 3.714
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.